Project Grant R01DC021320

Award Date 7/1/24
Completion Date 6/30/25
Dollars Obligated $1.4M
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Nebraska, USA
Similar Awards
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $586,022 to the University of Texas at Austin to conduct research on the functional consequences of early childhood otitis media (OM). The overarching goal is to understand the residual effects of early childhood OM on the development of functional listening skills. The research will...
This Project Grant award of $179,919, provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA Program 93.173 "Research Related to Deafness and Communication Disorders", will support Dr. Kavita Dedhia's research on the effectiveness of adjuvant adenoidectomy in the surgical management of otitis media. The key objectives are to: 1) Evaluate the effectiveness of adjuvant adenoidectomy and identify heterogeneity of treatment effects based on...
This federal Project Grant award of $1,403,696, provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), aims to use optical coherence tomography (OCT) imaging to visualize the fluid compartments of the human inner ear. The primary objectives are to: 1) Characterize the normal endolymph-to-perilymph ratio in control subjects undergoing mastoid surgery, and 2) Compare the...
This Project Grant award of $305,628 from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will support Echogenesis Therapeutics Inc.'s development of a cell-type-specific gene therapy approach for TOMT-linked congenital hearing loss. The project aims to establish proof-of-concept for a precision medicine therapy that can precisely target cochlear hair cells to restore hearing...
This Project Grant award of $713,170 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund the development and validation of a Multimodality Micro-Optical Coherence Tomography (MM-MOCT) technology. This innovative imaging system will obtain high-resolution structural and metabolic information about the critical sensorineural cells and nerve fibers in the human cochlea....
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (CFDA 93.173 - Research Related to Deafness and Communication Disorders) aims to uncover the molecular basis of otosclerosis, an age-related bone disorder causing hearing loss. The $533,978 award to the University of Arizona will fund a multi-pronged research approach over a 5-year period from March 2025 to January 2030. The project will analyze rare genetic variants in large otosclerosis families,...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will support research to examine the effects of background noise on real-time speech processing efficiency in school-age children with normal hearing and children using hearing aids. The $295,840 award will fund a study using eye-tracking technology to investigate the impacts of speech-shaped noise...
The federal Project Grant award R01DC020962 for $656,723.00, granted by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports research to validate a new protocol for recording Distortion Product Otoacoustic Emissions (DPOAEs) and expand their clinical applications. The key objectives are to: Validate a new DPOAE recording protocol using frequency-specific stimulus...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA 93.173 "Research Related to Deafness and Communication Disorders" is funding research at Oregon Health & Science University (OHSU) to investigate binaural integration of spectral and temporal information in individuals with hearing loss and hearing devices. The $662,162 award, effective April 4, 2025 through March 31, 2030, aims to address gaps in understanding...
Pionear Technologies Inc. received a $699,002 Project Grant award from the National Institute on Deafness and Other Communication Disorders within the Department of Health and Human Services. The award is part of the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173) to develop novel liquid-infused tympanostomy tubes with optimized lumen geometry and slippery material design. The goal of the project is to engineer tympanostomy tubes that more efficiently...

HEARING LOSS, PROGNOSIS, AND LONG-TERM IMPACT OF OTITIS MEDIA WITH EFFUSION IN CHILDREN - PROJECT SUMMARY/ABSTRACT OTITIS MEDIA WITH EFFUSION (OME) IS A COMMON CHILDHOOD CONDITION CHARACTERIZED BY A NON-PURULENT EFFUSION IN THE MIDDLE-EAR SPACE. OME CAN CAUSE CONDUCTIVE HEARING LOSS (CHL), BUT HEARING STATUS VARIES SUBSTANTIALLY FROM NORMAL HEARING TO MODERATE HEARING LOSSES (0-55 DB HL), AND EPISODES OF OME CAN LAST FOR VARIABLE LENGTHS OF TIME. CLINICAL EQUIPOISE EXISTS AS TO WHETHER TO TREAT OME (I.E., SURGICAL TUBE PLACEMENT) OR WAIT FOR IT TO RESOLVE SPONTANEOUSLY. WHILE THERE ARE RISKS ASSOCIATED WITH SURGERY IN YOUNG CHILDREN, WAITING FOR OME TO RESOLVE SPONTANEOUSLY MAY ALSO CARRY RISKS. OME HAS BEEN ASSOCIATED WITH LONG-TERM DEFICITS IN SPEECH, LANGUAGE, AND AUDITORY PROCESSING. HOWEVER, FINDINGS FROM CLINICAL STUDIES ARE VARIABLE, RESULTING IN A PERSISTENT DEBATE REGARDING THE LONG-TERM SEQUELAE OF OME. WE HYPOTHESIZE THAT A KEY RISK FACTOR FOR LONG-TERM DEFICITS IS THE CUMULATIVE AUDITORY DEPRIVATION ASSOCIATED WITH OME-RELATED CHL, NOT BY THE PRESENCE OF OME ITSELF. IF THIS IS THE CASE, ONLY A SUBSET OF CHILDREN WITH OME (THOSE WITH NOTABLE HEARING LOSSES) WOULD BE AT RISK OF LONG-TERM DEFICITS. AS SUCH, IT IS CRITICAL THAT WE DETERMINE THE HEARING STATUS OF ALL CHILDREN WITH OME AS WELL AS UNDERSTAND THE VARIABILITY IN THE EFFECTS OF THIS HEARING LOSS ON LONG-TERM OUTCOMES AS A FUNCTION OF THE DEGREE AND SYMMETRY OF THE LOSS. WHILE CURRENT DIAGNOSTIC TOOLS CAN OFTEN INDICATE THE PRESENCE OR ABSENCE OF OME, THERE ARE SIGNIFICANT LIMITATIONS IN OUR ABILITY TO DETERMINE THE PRESENCE, DEGREE, AND SYMMETRY OF THE CHL ASSOCIATED WITH OME DUE TO THE CHALLENGES WITH BEHAVIORAL AUDIOLOGICAL TESTING IN YOUNG CHILDREN, AND NO OBJECTIVE ALTERNATIVE TO BEHAVIORAL TESTING CURRENTLY EXISTS. FURTHER, EVEN IN CASES WHERE HEARING STATUS CAN BE DETERMINED BEHAVIORALLY, DETERMINATION OF HEARING AT ONE TIME POINT DOES NOT INDICATE THE STABILITY OF HEARING THRESHOLDS OR THE RISK AND MAGNITUDE OF LONG-TERM DEFICITS. OUR LONG-TERM GOAL IS TO ADDRESS THESE KNOWLEDGE GAPS COMPREHENSIVELY TO REFINE CLINICAL PRACTICE GUIDELINES BY IDENTIFYING CHILDREN MOST AT RISK FOR LONG-TERM DEFICITS TO IMPROVE TREATMENT RECOMMENDATIONS. AS A FIRST STEP, THE PRIMARY OBJECTIVE OF THIS PROPOSAL IS TO IMPROVE THE DIAGNOSIS AND UNDERSTANDING OF OME AND ITS RELATED HEARING LOSS AND INVESTIGATE THE INFLUENCE OF VARIABILITY IN CUMULATIVE AUDITORY DEPRIVATION ON ONE SEQUELA OF OME, BINAURAL PROCESSING. IN AIM 1, WE WILL DEVELOP A NON-INVASIVE OBJECTIVE ESTIMATE OF HEARING LOSS DUE TO OME. IN AIM 2, WE WILL CHARACTERIZE THE SHORT-TERM STABILITY AND PERSISTENCE OF OME AND ITS RELATED HEARING LOSS AND DETERMINE THE PROGNOSTIC VALUE OF A NON-INVASIVE MEASURE OF MIDDLE-EAR MECHANICS. IN AIM 3, WE WILL DETERMINE THE INFLUENCE OF OME-RELATED VARIATIONS IN CHL AND MIDDLE-EAR MECHANICS ON INDIVIDUAL DIFFERENCES IN BINAURAL PROCESSING. COMPLETION OF THESE AIMS WILL ACHIEVE A FIRST STEP TOWARD OUR LONG-TERM GOAL OF UNDERSTANDING THE CONSEQUENCES OF OME AND DEVELOPING TOOLS TO IDENTIFY CHILDREN MOST AT RISK FOR NEGATIVE SEQUELAE BY BOTH IMPROVING OUR ABILITY TO OBJECTIVELY DETERMINE PROGNOSIS AND HEARING STATUS OVER TIME AND IMPROVING OUR UNDERSTANDING OF HOW THESE FACTORS CONTRIBUTE TO INDIVIDUAL VARIABILITY IN LONG-TERM OUTCOMES.

Posted 4/12/24, 12:00 AM